Attenuated gastropathy but not enteropathy of diclofenac-cholestyramine complex in rats

Drug Development Research

Volumn 64, Issue 1, 2005, Pages 19-27

  Ramírez Alcántara, Verónica ^a,b   Castañeda Hernández, Gilberto ^b   Rampy, Bill Alan ^a   Aronson, Judith F ^a   Treinen Moslen, Mary ^a,c  

^a University of Texas Medical Branch School of Medicine   (United States)

^b DEPARTAMENTO DE FÍSICA   (Mexico)

^c UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

Author keywords

Cholestyramine; Diclofenac; Enteropathy; Flotac; Gastropathy

Indexed keywords

BILE SALT; COLESTYRAMINE; DICLOFENAC; DICLOFENAC COLESTYRAMINE; NONSTEROID ANTIINFLAMMATORY AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CYTOTOXICITY; DIGESTIVE SYSTEM ULCER; DRUG FORMULATION; ENTEROPATHY; FEEDING; GASTROINTESTINAL MUCOSA; INFLAMMATION; MALE; MEXICO; NONHUMAN; PAIN; RAT; STOMACH DISEASE; TREATMENT OUTCOME;

EID: 18044389503     PISSN: 02724391     EISSN: None     Source Type: Journal    
DOI: 10.1002/ddr.10417     Document Type: Article

References (30)

1. Al-Balla SR, El-Sayed YM, Al-Meshal MA, Gouda MW. 1994. The effects of cholestyramine and colestipol on the absorption of diclofenac in man. Int J Clin Pharmacol Ther 32:441-445.
2. Atchison CR, West AB, Balakumaran A, Hargus SJ, Pohl LR, Daiker DH, Aronson JF, Hoffmann WE, Shipp BK, Treinen-Moslen M. 2000a. Drug enterocyte adducts: possible causal factor for diclofenac enteropathy in rats. Gastroenterology 119:1537-1547.
3. Atchison CR, Balakumaran A, West B, Hoffmann W, Tremen-Moslen M. 2000b. Aging enhances susceptibility of diclofenac-treated rats to gastric ulceration, while attenuating enteropathy. Dig Dis Sci 45:614-620.
4. Banks AT, Zimmerman HJ, Ishak KG, Harter JG. 1995. Diclofenac-associated hepatotoxicity: analysis of 180 cases reported to the food and drug administration as adverse reactions. Hepatology 22:820-827.
5. Beck WS, Schneider HT, Dietzel K, Nuernberg B, Brune K. 1990. Gastrointestinal ulcerations induced by anti-inflammatory drugs in rats. Physicochemical and biochemical factors involved. Ann Toxicol 64:210-217.
6. Bennet WM, Henrich WL, Stoff JS. 1996. The renal effects of nonsteroidal anti-inflammatory drugs: summary and recommendations. Am J Kidney Dis 28:1(suppl 1):S56-S62.
7. Bjarnason I, Takeuchi K, Simpson R. 2003. NSAIDs: the emperor's new dogma? Gut 52:1376-1378.
8. Boelsterli UA. 2003. Diclofenac-induced liver: a paradigm of idiosyncratic drug toxicity. Toxicol Appl Pharmacol 192:307-322.
9. Castañeda-Hernández G, Zazueta-Montiel B, Granados-Soto V, Torres-López JE, Pérez-Urizar JT, Rosas-Ramos R. 2001. Analgesic efficacy and pharmacokinetic and pharmacodynamic bases of diclofenac cholestyramine, an improved diclofenac formulation. Ann Rheum Dis 60(suppl I):308.
10. Choi VM, Coates JE, Chooi J, Thomson AB, Russell AS. 1995. Small bowel permeability-a variable effect of NSAIDs. Clin Invest Med 18:357-361.
11. Davies NM, Jamali F. 1997. Influence of dosage form on the gastroenteropathy of flurbiprofen in the rat: evidence of shift in the toxicity site. Pharm Res 14:1597-1600.
12. FitzGerald GA, Patrono C. 2001. The coxibs, selective inhibitors of cyclooxygenase-2. N Engl J Med 345:433-442.
13. Khazaeinia T, Jamali F. 2004. Effect of drug release rate on therapeutic outcomes: formulation dependence of gastrointestinal toxicity of diclofenac in the rat. Inflammopharmacology 12:69-80.
14. Koss FW, Mayer D, Haindl H. 1974. Bile acids. Methods Enzymol Anal 4:1886-1888.
15. Kurowski M, Menninger H, Pauli E. 1994. The efficacy and relative bioavailabiliry of diclofenac resinate in rheumatoid arthritis patients. Int J Clin Pharmacol Ther 32:433-440.
16. Lichtenberger LM. 2001. Where is the evidence that cyclooxygenase inhibition is the primary cause of nonsteroidal anti-inflammatory drug (NSAID)-induced gastrointestinal injury? Topical injury revisited. Biochem Pharmacol 61:631-637.
17. Med Ad News. 2004. Top 400 prescription drugs by worldwide sales 2004. www.pharmalive.com, Special reports. May 2004.
18. + channels by diclofenac. Eur J Clin Pharmacol 438:85-91.
19. Satoh H, Guth PH, Grossman MI. 1982. Role of food in gastrointestinal ulceration produced by indomethacin in the rat. Gastroenterology 83:210-215.
20. Seitz S, Boelsterli UA. 1998. Diclofenac acyl glucuronide, a major biliary metabolite, is directly involved in small intestinal injury in rats. Gastroenterology 115:1476-1482.
21. Silva LC, Simoes IG, Lerner FE, Belem GR, de Moraes ME, De Nucci G. 1999. Comparative bioavailability of two different diclofenac formulations in healthy volunteers. Arzneim-Forsch/ Drug Res 49:920-924.
22. Teng XW, Abu-Mellal AK, Davies NM. 2003. Formulation dependent pharmacokinetics, bioavailability and renal toxicity of a selective cyclooxygenase-1 inhibitor SC-560 in the rat. J Pharm Pharm Sci 6:205-210.
23. Tibble JA, Sigthorsson G, Foster R, Scott D, Fagerhol MK, Roseth A, Bjarnason I. 1999. High prevalence of NSAID enteropathy as shown by a simple faecal test. Gut 45:362-366.
24. Tomisato W, Tsutsumi S, Hoshino T, Hwang H-J, Mio M, Tsuchiya T, Mizushima T 2004. Role of direct cytotoxic effects of NSAIDs in the induction of gastric lesions. Biochem Pharmacol 67:575-585.
25. van Breemen RB, Fenselau CC. 1986. Reaction of 1-O-acyl glucuronides with 4-(p-nitrobenzyl)pyridine. Drug Metab Dispos 14:197-201.
26. Wallace JL, Reuter B, Cicala C, McKnight W, Grisham M, Cirino G. 1994. A diclofenac derivative without ulcerogenic properties. Eur J Pharmacol 257:249-255.
27. Wallace JL, McKnight W, Reuter BK, Vergnolle N. 2000. NSAID-induced gastric damage in rats: requirement for inhibition of both cyclooxygenase 1 and 2. Gastroenterology 119:706-714.
28. Warner TD, Giuliano F, Vojnovic I, Bukasa A, Mitchell JA, Vane JR. 1999. Nonsteroid drug selectivities for cyclo-oxygenase-1 rather than cyclo-oxygenase-2 are associated with human gastrointestinal toxicity: a full in vitro analysis. Proc Natl Acad Sci 96:7563-7568.
29. Wax J, Clinger WA, Varner P, Bass P, Winder CV. 1970. Relationship of the enterohepatic cycle to ulcerogenesis in the rat small bowel with flufenamic acid. Gastroenterology 58:772-780.
30. Whittle BJ. 2003. New dogmas or old? Gut 52:1379-1381.